← Leaderboards
Trevor Martin Twose
Mithridion, Inc.
$1,190,546
Attributed
$1,190,546
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $446.8K · FY2006–09$500K$375K$250K$125K$0
'06
'07
'08
'09
Funding mix
By agency
NIH$1,190,546 · 3
By mechanism
R44$893,688 · 1
R41$154,187 · 1
R43$142,671 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cognitive Deficits”
- Lennart Mucke · Scripps Research Institute$34,873,389
- Vinod Menon · Stanford University$33,263,107
- David A Lewis · University Of Pittsburgh At Pittsburgh$30,436,462
- Raquel E Gur · University Of Pennsylvania$29,186,835
- Richard W Tsien · New York University School Of Medicine$27,675,342
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,197,236
Research focus
Cognitive DeficitsCognitive FunctionAgonistAdenylate Cyclase2-Cyclopentyl-5-(5-Isoquinolylsulfonyl)-6-Nitro-1h-Benzo(D)ImidazoleAnalytical MethodAnimal ModelAnimalsAnalogApomorphineAffinityBackBaseBinding (Molecular Function)Blood - Brain Barrier AnatomyBrainCanis FamiliarisCell LineCellsAntipsychotic AgentsClinical TrialsCognitionAttentionDisability
Grant awards (4)
Development of a Selective Muscarinic Agonist for the Treatment of Schizophrenia$446,844
R44 · FY2009 · MH · contact PI
Development of a Selective Muscarinic Agonist for the Treatment of Schizophrenia$446,844
R44 · FY2008 · MH · contact PI
Neuroprotective Drugs for Alzheimer's Disease$154,187
R41 · FY2006 · AG · contact PI
Identification of Neuroactive Peptides protective against Alzheimer's disease$142,671
R43 · FY2006 · AG · contact PI